Average Co-Inventor Count = 3.90
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Seattle Genetics, Inc. (24 from 132 patents)
2. Seagen Inc. (1 from 64 patents)
3. Psma Development Company, LLC (5 patents)
25 patents:
1. 11319526 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
2. 10808039 - Monomethylvaline compounds capable of conjugation to ligands
3. 10443035 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
4. 10414826 - Monomethylvaline compounds capable of conjugation to ligands
5. 9816069 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
6. 8993326 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
7. 8906376 - Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
8. 8703714 - Monomethylvaline compounds capable of conjugation to ligands
9. 8574907 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
10. 8557780 - Monomethylvaline compounds capable of conjugation to ligands
11. 8163551 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
12. 7994135 - Monomethylvaline compounds capable of conjugation to ligands
13. 7964567 - Monomethylvaline compounds capable of conjugation to ligands
14. 7964566 - Monomethylvaline compounds capable of conjugation to ligands
15. 7851437 - Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease